# Otolaryngology (otology/neurotology) Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Martin Luther (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE004-SYN
- Date: 2026-08-11
- Fictional facility: St. Posthumous Health Center
- Fictional author: Friedrich Okafor-Lindqvist, MD
- Calendar frame: modern shifted

- Requested by: Ottilie Brandt-Mensah, MD

## Reason for consultation

Recurrent attacks of spinning vertigo for about three months, lasting hours, with roaring tinnitus, fullness and muffled hearing in the left ear, in a 43-year-old man; the tinnitus persists between attacks. Please confirm the cause, arrange audiometry and any imaging, and advise on preventing attacks and protecting his hearing. **S**

## History

Professor Luther, 43, is seen at the request of Dr. Brandt-Mensah. Over about three months he has had three attacks of spinning vertigo, and one more six days ago, each lasting from about one to six hours, with nausea, and each preceded or accompanied by roaring tinnitus and fullness in the left ear and muffled hearing on that side. Between attacks the left-ear tinnitus continues at a lower level. He does not lose consciousness. No attack has come with headache, light or sound sensitivity, or visual aura; he has dull headaches on some other days, without dizziness, and had head and ear noises in his twenties. No ear discharge, ear surgery, head injury or ototoxic drugs. He drinks three to four cups of coffee a day and beer with dinner, and his diet is salty. He is frightened of an attack while preaching or lecturing. **S**

## Examination

| System | Finding |
|---|---|
| Ears | Ear canals and tympanic membranes normal on microscopy; tuning forks: Weber to the right, Rinne positive on both sides |
| Eyes and vestibular | No spontaneous or gaze-evoked nystagmus with fixation removed; head impulse test normal on both sides; no head-shake nystagmus |
| Neurological | Cranial nerves normal, including facial and trigeminal function; coordination normal; gait and Romberg steady |

BP 126/80 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 86.2 kg; BMI 28.1 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Brandt-Mensah's intake note, examination and tests (blood count, electrolytes, kidney function, calcium, uric acid and TSH normal) and his attack diary. Audiometry today: left low-frequency sensorineural hearing loss of 40 dB at 250 and 500 Hz and 30 dB at 1000 Hz, 15 to 20 dB above that; right ear normal; word recognition 88 percent left and 100 percent right; type A tympanograms on both sides. PHQ-9: 14. All results are synthetic.

## Assessment

1. **Ménière disease of the left ear, definite** (H81.02). He meets the AAO-HNS 2020 and Bárány Society criteria for definite Ménière disease: two or more spontaneous attacks of vertigo each lasting 20 minutes to 12 hours, low- to medium-frequency sensorineural hearing loss documented by audiometry in the left ear, and fluctuating tinnitus and fullness in that ear, not better explained by another vestibular diagnosis. The normal examination between attacks argues against a central cause. Vestibular migraine was considered: he has headaches, but no attack has carried migraine features, so the criteria for vestibular migraine are not met; the two can coexist, and a headache diary will show whether that is so. The asymmetric hearing loss calls for MRI to exclude a vestibular schwannoma. Vestibular function testing and electrocochleography are not needed to make the diagnosis. **S**
2. **Maintenance treatment**. Sodium restriction and limiting caffeine and alcohol are reasonable first steps. A diuretic is a guideline option for maintenance; hydrochlorothiazide also lowers urine calcium, which may help his stones, but his sodium should be checked, particularly if an SSRI is started. Betahistine is not FDA approved in the United States and the large BEMED trial found it no better than placebo, so it is not recommended. Vestibular suppressants such as meclizine should be limited to attacks, because regular use slows compensation. **S**
3. **Hearing, tinnitus and balance**. Hearing is fluctuating and word recognition is still good; no hearing aid is needed now. If unsteadiness persists between attacks, vestibular rehabilitation helps; it is not useful during an attack. If disabling attacks continue after about three months of these measures, an intratympanic steroid injection is the next step; gentamicin or surgery are reserved for refractory disease. **S**

## Recommendations

1. Sodium 1,500 to 2,300 mg a day, caffeine to about one cup a day, and alcohol limited; keep the attack and headache diary.
2. Hydrochlorothiazide 25 mg each morning, with sodium and potassium in two to four weeks.
3. No betahistine.
4. Meclizine only for severe attacks, for no more than three days at a time; sit or lie down at the first warning.
5. MRI of the internal auditory canals with gadolinium.
6. Vestibular rehabilitation if unsteadiness persists between attacks.
7. Repeat audiogram at about three months, and sooner with any change in hearing.
8. Intratympanic steroid if disabling attacks continue after about three months.
9. Depression care to continue with Dr. Brandt-Mensah; the attacks and the fear of them feed the low mood.

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Communication

Discussed with Dr. Brandt-Mensah, who saw him the same day. The diagnosis, the reasons for the MRI, the decision against betahistine and the plan were explained to Professor Luther, who was relieved to have a name for the attacks and agreed to the plan. **S**

## Follow-up

Otology review in three months with the repeat audiogram, or sooner if attacks continue or hearing changes. **S**

## Guideline basis

- Clinical Practice Guideline: Ménière's Disease (2020), American Academy of Otolaryngology-Head and Neck Surgery Foundation (Basura GJ, et al. Otolaryngol Head Neck Surg 2020;162(2 Suppl):S1-S55)
- Diagnostic criteria for Menière's disease (2015), Bárány Society Classification Committee (Lopez-Escamez JA, et al. J Vestib Res 2015;25(1):1-7)
- Vestibular migraine: diagnostic criteria (update) (2022), Bárány Society and International Headache Society (Lempert T, et al. J Vestib Res 2022;32(1):1-6)
- Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial) (2016), BMJ (Adrion C, et al. BMJ 2016;352:h6816)
